Literature DB >> 8633198

Intranasal inoculation of Bordetella bronchiseptica in mice induces long-lasting antibody and T-cell mediated immune responses.

P Gueirard1, P Minoprio, N Guiso.   

Abstract

Humoral and cellular immune responses were analysed in mice inoculated intranasally with Bordetella bronchiseptica. After infection, the number of bacteria that colonized the respiratory tract of the mice increased during the first day and decreased thereafter. Total IgG levels increased as early as 14 days after infection and decreased with time after infection, whereas total IgA and IgM levels were lower but remained stable. Specific antibodies to the bacteria were mainly IgG2a and IgA and persisted up to 10 months after infection. Some of these specific antibodies were directed against adenylate cyclase-haemolysin, the bacterial factor that had been shown to be necessary for initiation of infection. The proliferation of Bordetella bronchiseptica-reactive spleen cells occurred during the acute phase of infection. T cells from infected mice produced increasing amounts of IFN gamma and IL-2 after infection. Although very low levels of IL-10 were produced, no IL-4 was detected after bacterial stimulation in vitro. These results suggest that Bordetella bronchiseptica infection induces primarily a Th1-type T-cell response. Importantly, the authors demonstrated that antibody and T-cell responses directed against bacterial determinants of the virulent strain and to purified adenylate cyclase-haemolysin were long-lasting. This observation could be due to the fact that Bordetella bronchiseptica may persist intracellularly in the host as it was demonstrated in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633198     DOI: 10.1046/j.1365-3083.1996.d01-30.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract.

Authors:  Pascale Gueirard; Patrick Ave; Anne-Marie Balazuc; Sabine Thiberge; Michel Huerre; Genevieve Milon; Nicole Guiso
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes.

Authors:  A Banemann; R Gross
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Infection with Salmonella typhimurium modulates the immune response to Schistosoma mansoni glutathione-S-transferase.

Authors:  E E Comoy; C Vendeville; A Capron; G Thyphronitis
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response.

Authors:  S Mattoo; J F Miller; P A Cotter
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Phagosome acidification has opposite effects on intracellular survival of Bordetella pertussis and B. bronchiseptica.

Authors:  B Schneider; R Gross; A Haas
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity.

Authors:  E T Harvill; P A Cotter; M H Yuk; J F Miller
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

7.  Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica.

Authors:  Neelima Sukumar; Cheraton F Love; Matt S Conover; Nancy D Kock; Purnima Dubey; Rajendar Deora
Journal:  Infect Immun       Date:  2008-12-08       Impact factor: 3.441

Review 8.  Bordetella Adenylate Cyclase-Hemolysin Toxins.

Authors:  Nicole Guiso
Journal:  Toxins (Basel)       Date:  2017-09-11       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.